Benign paroxysmal positional vertigo secondary prevention: Difference between revisions
Created page with "__NOTOC__ {{Benign paroxysmal positional vertigo}} {{CMG}}; {{AE}} {{Fs}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR..." |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no established measures for the | There are no established measures for the [[secondary prevention]] of BPPV. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
There are no established measures for the | There are no established measures for the [[secondary prevention]] of BPPV. | ||
==References== | ==References== |
Latest revision as of 16:21, 5 March 2019
Benign paroxysmal positional vertigo Microchapters |
Differentiating Benign Paroxysmal Positional Vertigo from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Benign paroxysmal positional vertigo secondary prevention On the Web |
American Roentgen Ray Society Images of Benign paroxysmal positional vertigo secondary prevention |
FDA on Benign paroxysmal positional vertigo secondary prevention |
CDC on Benign paroxysmal positional vertigo secondary prevention |
Benign paroxysmal positional vertigo secondary prevention in the news |
Blogs on Benign paroxysmal positional vertigo secondary prevention |
Risk calculators and risk factors for Benign paroxysmal positional vertigo secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
There are no established measures for the secondary prevention of BPPV.
Secondary Prevention
There are no established measures for the secondary prevention of BPPV.